巴瑞克替尼是一种治疗类风湿性关节炎（RA）的药物，是由英格尔和伊莉莉开发的。它作为JAK激酶的抑制剂，阻断JAK1和JAK2亚型。该药在欧洲获得批准。
Diphenylmethanamine
4-(1-(1-Ethoxyethyl)-1H-pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine
tert-Butyl 3-(cyanomethylene)azetidine-1-carboxylate
1-(1-Ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
4-Chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine
2-(3-(4-(3H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile
1-Benzhydrylazetidin-3-ol
Epichlorohydrin
1-Benzhydrylazetidin-3-ol hydrochloride
